Literature DB >> 24464976

Surgical management of perihilar cholangiocarcinoma: a Khon Kaen experience.

Narong Khuntikeo1, Ake Pugkhem, Attapol Titapun, Vajarabhongsa Bhudhisawasdi.   

Abstract

Cholangiocarcinoma is the most common cancer in the northeast of Thailand. Most of the patients present when the disease is in an advanced stage. Improvement of preoperative diagnoses and surgical techniques provide more satisfactory results. Herein we reviewed our 30-year experience in management of perihilar cholangiocarcinoma in Khon Kaen northeast Thailand. Between 1982 and 2012 we reviewed four specific studies of perihilar cholangiocarcinoma in Srinagarind Hospital, Khon Kaen, Thailand. The first study focused on advanced surgical pathology and palliative surgery, which were used to treat obstructive jaundice cholangiocarcinoma patients. Long-term survival in this study was rare with a one-year survival of just 15%. The second study was conducted on 30 consecutive cases of perihilar cholangiocarcinoma who presented with obstructive jaundice without preoperative biliary drainage. All the patients underwent major liver resection with bilio-enteric reconstruction. Perioperative mortality was 6.7% without a 5-year survival. The third study aimed to analyze the survival rates and factors affecting survival in extrahepatic CCA patients following surgical treatment at Srinagarind Hospital and concluded that resection margins are an important prognostic factor. The last study objective was the analysis of curative surgical attempt in 99 consecutive perihilar cholangiocarcinoma and results showed that R0 resection could improve long-term survival. We evaluated four studies of perihilar cholangiocarcinoma in Srinagarind Hospital, Khon Kaen, Thailand from 1982-2012. Viewed chronologically there has been a progressive improvement of diagnosis and surgical treatment during the past 30 years. Despite these advances the 5-year survival rate remains unsatisfactorily low. Future improvement of patient selection and surgical techniques can lead to a greater survival rate for patients.
© 2014 Japanese Society of Hepato-Biliary-Pancreatic Surgery.

Entities:  

Keywords:  Extrahepatic cholangiocarcinoma; Hepatic resection; Obstructive jaundice; Perihilar cholangiocarcinoma

Mesh:

Year:  2014        PMID: 24464976     DOI: 10.1002/jhbp.74

Source DB:  PubMed          Journal:  J Hepatobiliary Pancreat Sci        ISSN: 1868-6974            Impact factor:   7.027


  13 in total

1.  Outcome of curative resection for perihilar cholangiocarcinoma in Northeast Thailand.

Authors:  Attapol Titapun; Ake Pugkhem; Vor Luvira; Tharatip Srisuk; Ongart Somintara; O-Tur Saeseow; Anan Sripanuskul; Anongporn Nimboriboonporn; Bandit Thinkhamrop; Narong Khuntikeo
Journal:  World J Gastrointest Oncol       Date:  2015-12-15

2.  Clinicopathological Significance of Osteopontin in Cholangiocarcinoma Cases.

Authors:  Marut Laohaviroj; Yaovalux Chamgramol; Chawalit Pairojkul; Jason Mulvenna; Banchob Sripa
Journal:  Asian Pac J Cancer Prev       Date:  2016

3.  Teleconsultation ultrasonography: a new weapon to combat cholangiocarcinoma.

Authors:  Nittaya Chamadol; Vallop Laopaiboon; Jiraporn Srinakarin; Watcharin Loilome; Puangrat Yongvanit; Bandit Thinkhamrop; Narong Khuntikeo
Journal:  ESMO Open       Date:  2017-08-22

4.  Evaluating a preoperative protocol that includes magnetic resonance imaging for lymph node metastasis in the Cholangiocarcinoma Screening and Care Program (CASCAP) in Thailand.

Authors:  Metha Songthamwat; Nittaya Chamadol; Narong Khuntikeo; Jadsada Thinkhamrop; Supinda Koonmee; Nathaphop Chaichaya; Jeffrey Bethony; Bandit Thinkhamrop
Journal:  World J Surg Oncol       Date:  2017-09-20       Impact factor: 2.754

5.  In vitro and in vivo Anti-Tumor Effects of Pan-HER Inhibitor Varlitinib on Cholangiocarcinoma Cell Lines.

Authors:  Hasaya Dokduang; Wassana Jamnongkarn; Bundit Promraksa; Manida Suksawat; Sureerat Padthaisong; Malinee Thanee; Jutarop Phetcharaburanin; Nisana Namwat; Sakkarn Sangkhamanon; Attapol Titapun; Narong Khuntikeo; Poramate Klanrit; Watcharin Loilome
Journal:  Drug Des Devel Ther       Date:  2020-06-11       Impact factor: 4.162

6.  Improving the Detection of Cholangiocarcinoma: In vitro MRI-Based Study Using Local Coils and T2 Mapping.

Authors:  Narong Khuntikeo; Attapol Titapun; Nittaya Chamadol; Wuttisak Boonphongsathien; Prakasit Sa-Ngiamwibool; Simon D Taylor-Robinson; Christopher A Wadsworth; Shuo Zhang; Evdokia M Kardoulaki; Ian R Young; Richard R A Syms
Journal:  Hepat Med       Date:  2020-03-24

7.  Ultrasound screening for cholangiocarcinoma could detect premalignant lesions and early-stage diseases with survival benefits: a population-based prospective study of 4,225 subjects in an endemic area.

Authors:  Prakongboon Sungkasubun; Surachate Siripongsakun; Kunlayanee Akkarachinorate; Sirachat Vidhyarkorn; Akeanong Worakitsitisatorn; Thaniya Sricharunrat; Sutida Singharuksa; Rawisak Chanwat; Chairat Bunchaliew; Sirima Charoenphattharaphesat; Ruechuta Molek; Maneenop Yimyaem; Gaidganok Sornsamdang; Kamonwan Soonklang; Kasiruck Wittayasak; Chirayu U Auewarakul; Chulabhorn Mahidol
Journal:  BMC Cancer       Date:  2016-06-02       Impact factor: 4.430

8.  A Comprehensive Public Health Conceptual Framework and Strategy to Effectively Combat Cholangiocarcinoma in Thailand.

Authors:  Narong Khuntikeo; Watcharin Loilome; Bandit Thinkhamrop; Nittaya Chamadol; Puangrat Yongvanit
Journal:  PLoS Negl Trop Dis       Date:  2016-01-21

9.  Antifibrotic effect of xanthohumol in combination with praziquantel is associated with altered redox status and reduced iron accumulation during liver fluke-associated cholangiocarcinogenesis.

Authors:  Wassana Jamnongkan; Malinee Thanee; Puangrat Yongvanit; Watcharin Loilome; Raynoo Thanan; Phongsaran Kimawaha; Tidarat Boonmars; Runglawan Silakit; Nisana Namwat; Anchalee Techasen
Journal:  PeerJ       Date:  2018-01-22       Impact factor: 2.984

10.  Cryptotanshinone induces cell cycle arrest and apoptosis through the JAK2/STAT3 and PI3K/Akt/NFκB pathways in cholangiocarcinoma cells.

Authors:  Fayong Ke; Zheng Wang; Xiaoling Song; Qiang Ma; Yunping Hu; Lin Jiang; Yijian Zhang; Yingbin Liu; Yong Zhang; Wei Gong
Journal:  Drug Des Devel Ther       Date:  2017-06-15       Impact factor: 4.162

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.